Comments
Shares of Ajanta Pharma on Wednesday shot up by 20 per cent to touch the upper circuit limit, after the company reported 75.95 per cent increase in net profit for the third quarter ended December 31, 2012.
Following the strong set of numbers, shares of the company soared 19.99 per cent to Rs 490.65 —— its upper circuit limit on the BSE.
At NSE, the stock jumped 20 per cent to Rs 491.45.
On the volume front, 5.62 lakh shares of the company changed hands on the BSE, while over 11 lakh shares were traded on NSE.
Ajanta Pharma today reported 75.95 per cent increase in net profit to Rs 32.57 crore for the quarter ended December 31, 2012, mainly on robust sales.
The company had posted a net profit of Rs 18.51 crore for the corresponding period previous fiscal.
Net sales of the company rose to Rs 225.68 for the quarter under review from Rs 164.52 crore for the same period last fiscal.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.